跳至主要内容
临床试验/NCT02794584
NCT02794584已完成不适用

Precision Assessment of Perioperative Effectiveness and Safety of Transthoracic Minimally Invasive Hybrid Closure for Pediatric Ventricular Septal Defects

Nanjing Medical University0 个研究点目标入组 200 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
主要终点
Respiratory dysfunction as measured by PaO2

研究概览

简要总结

Ventricular septal defect (VSD) is one of the most common pediatric congenital malformations. In recent years, in view of the rapid rise of transthoracic minimally invasive hybrid closure for pediatric VSD in the clinical practice, precision assessment of perioperative its effectiveness and safety has already become an important issue that must be solved. On the basis of echocardiography, integrating with characteristics associated critical care, the investigators focus on precision assessment of perioperative effectiveness and safety of transthoracic hybrid closure for pediatric VSD, compared with conventional surgical sternotomy repair with cardiopulmonary bypass (CPB).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • confirmed diagnosis of perimembranous ventricular septal defect, muscular ventricular septal defect, doubly committed subarterial VSD by transesophageal echocardiogram (TEE) with VSD size 5-12mm;
  • no significant aortic insufficiency or aortic valve prolapse.

排除标准

  • confirmed pulmonary hypertension (systolic pulmonary arterial pressure >75mmHg or pulmonary vascular resistance >8.0 Wood U/m2);
  • more than mild degree of aortic regurgitation and obvious aortic valve prolapse;
  • preoperative congestive heart failure;
  • other coexisting cardiac anomalies;
  • infective endocarditis.

研究组 & 干预措施

Off-pump hybrid closure

Active Comparator

Hybrid closure is that a periventricular technique uses an occluding device to closure ventricular septal defects of patients through the delivery system by transthoracic minimally invasive small incision without cardiopulmonary bypass.

干预措施: sufentanil anesthesia (Drug)

Off-pump hybrid closure

Active Comparator

Hybrid closure is that a periventricular technique uses an occluding device to closure ventricular septal defects of patients through the delivery system by transthoracic minimally invasive small incision without cardiopulmonary bypass.

干预措施: Hybrid closure (Procedure)

Control

Placebo Comparator

Control group: Conventional closure of ventricular septal defects was aided with cardiopulmonary bypass.

干预措施: sufentanil anesthesia (Drug)

Control

Placebo Comparator

Control group: Conventional closure of ventricular septal defects was aided with cardiopulmonary bypass.

干预措施: Control (Procedure)

结局指标

主要结局

Respiratory dysfunction as measured by PaO2

时间窗: 7 days postoperatively after cardiac surgery

Myocardial injury as measured by cardiac troponin I serum

时间窗: 7 days postoperatively after cardiac surgery

次要结局

  • All cause mortality(7 days postoperatively after cardiac surgery)

研究者

发起方
Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hong Liu

Principal Investigator

The First Affiliated Hospital with Nanjing Medical University

相似试验